Zhengye Biotechnology Holding (ZYBT) Payables (2023 - 2025)
Zhengye Biotechnology Holding (ZYBT) posted quarterly Payables of $15.4 million for Q4 2025, down 7.51% year-over-year from $16.6 million in Q4 2024, and down 11.58% quarter-over-quarter from $17.4 million in Q2 2025.
Zhengye Biotechnology Holding (ZYBT) Payables (2023 - 2025) Analysis & Trends
Zhengye Biotechnology Holding (ZYBT) has reported Payables for 3 consecutive years, with $15.4 million the latest figure, recorded in Q4 2025.
- In Q4 2025, Payables fell 7.51% year-over-year to $15.4 million; the TTM figure through Dec 2025 stood at $15.4 million (down 7.51% YoY), while the FY2025 annual figure was $15.4 million, down 6.03% from the prior year.
- Payables eased to $15.4 million in Q4 2025 per ZYBT's latest filing, from $17.4 million in the prior quarter.
- Across five years, Payables topped out at $19.6 million in Q4 2023 and bottomed at $15.4 million in Q4 2025.
- Historically, Payables has averaged $17.3 million across 3 years, with a median of $17.0 million in 2024.
- Annual changes were most pronounced in 2024 — Payables declined 15.17% — and 2025, when it declined 7.51%.
- Zhengye Biotechnology Holding's Payables stood at $19.6 million in 2023, then retreated by 15.17% to $16.6 million in 2024, then decreased by 7.51% to $15.4 million in 2025.
- Business Quant data shows ZYBT's Payables at $15.4 million in Q4 2025, $17.4 million in Q2 2025, and $16.6 million in Q4 2024.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.91 Bn | 42.95 Bn | - | -7.73 Bn |
| 2 | Teva Pharmaceutical Industries | 42.98 Bn | 39.32 Bn | 2.15 Bn | 2.72 Bn |
| 3 | Zoetis | 31.53 Bn | 29.86 Bn | 1.05 Bn | 673.00 Mn |
| 4 | Takeda Pharmaceutical | 28.61 Bn | 22.81 Bn | 5.10 Bn | 2.80 Bn |
| 5 | United Therapeutics | 22.16 Bn | 19.49 Bn | 683.80 Mn | 497.80 Mn |
| 6 | Viatris | 18.74 Bn | 17.85 Bn | 1.46 Bn | 1.73 Bn |
| 7 | Neurocrine Biosciences | 15.51 Bn | 15.12 Bn | 935.80 Mn | 808.30 Mn |
| 8 | Elanco Animal Health | 11.76 Bn | 11.23 Bn | 798.00 Mn | 427.00 Mn |
| 9 | Dr Reddys Laboratories | 10.12 Bn | 9.95 Bn | - | 986.00 Mn |
| 10 | Zhengye Biotechnology Holding | 85.23 Mn | 77.91 Mn | - | 15.38 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 15.38 Mn |
| Jun 30, 2025 | 17.40 Mn |
| Dec 31, 2024 | 16.63 Mn |
| Dec 31, 2023 | 19.61 Mn |